@article{e0700255005b4aa29dc361d6290d8341,
title = "A triple therapy regimen after failed Helicobacter pylori treatments",
abstract = "Following standard triple therapy, up to 20% of patients require further Helicobacter pylori eradication treatment. Data regarding the efficacy of re-treatment in these patients are scarce.",
keywords = "Adult, Aged, Anti-Bacterial Agents, Anti-Ulcer Agents, Antitrichomonal Agents, Biopsy, Bismuth, Breath Tests, Carbon Isotopes, Drug Therapy, Combination, Endoscopy, Gastrointestinal, Female, Helicobacter Infections, Helicobacter pylori, Humans, Male, Middle Aged, Ranitidine, Tetracycline, Tinidazole, Urea, Urease, Adult, Aged, Anti-Bacterial Agents, Anti-Ulcer Agents, Antitrichomonal Agents, Biopsy, Bismuth, Breath Tests, Carbon Isotopes, Drug Therapy, Combination, Endoscopy, Gastrointestinal, Female, Helicobacter Infections, Helicobacter pylori, Humans, Male, Middle Aged, Ranitidine, Tetracycline, Tinidazole, Urea, Urease",
author = "A Zullo and Cesare Hassan and Sm Campo and R Lorenzetti and I Febbraro and {De Matthaeis}, M and D Porto and S. Morini",
year = "2001",
language = "English",
volume = "15",
pages = "1193--1197",
journal = "ALIMENTARY PHARMACOLOGY & THERAPEUTICS",
issn = "0269-2813",
publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL:
[email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",
}